Cargando…
Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome
Imbalance in the metabolites levels which can potentially be related to certain fetal chromosomal abnormalities can stimulate mother's immune response to produce autoantibodies directed against proteins. The aim of the study was to determine the concentration of 9000 autoantibodies in maternal...
Autores principales: | Charkiewicz, Karol, Zbucka-Kretowska, Monika, Goscik, Joanna, Wolczynski, Slawomir, Lemancewicz, Adam, Laudanski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799815/ https://www.ncbi.nlm.nih.gov/pubmed/27042674 http://dx.doi.org/10.1155/2016/9362169 |
Ejemplares similares
-
Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2017) -
Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome
por: Laudanski, Piotr, et al.
Publicado: (2014) -
Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2015) -
Maternal Plasma Metabolomic Profiles in Spontaneous Preterm Birth: Preliminary Results
por: Lizewska, Barbara, et al.
Publicado: (2018) -
The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome
por: Buczyńska, Angelika, et al.
Publicado: (2020)